Butler Hospital
butler.orgTotal trials
116
Active
21
Phase 3
16
Total enrollment
56,698
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Electronic Cigarette | — | — | — | — | — | 1 | |
| Nicotine Lozenge | — | — | — | — | — | 1 | |
| Emtriva | — | — | — | — | — | 1 |
Next readouts
- 2025-06-30
- 2026-03-31
Top conditions
- Depression18
- Suicide8
- Major Depressive Disorder6
- HIV6
- Obsessive-Compulsive Disorder6
- Suicide and Self-harm5
- Suicidal Ideation5
- Bipolar Disorder4
Frequently asked questions about Butler Hospital
- How many clinical trials does Butler Hospital have on ClinicalTrials.gov?
- Butler Hospital is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Butler Hospital's trials are in Phase 3?
- 16 of Butler Hospital's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Butler Hospital focus on?
- Butler Hospital's most-studied conditions on ClinicalTrials.gov are Depression, Suicide, Major Depressive Disorder, HIV, Obsessive-Compulsive Disorder.
- When are Butler Hospital's next clinical trial readouts?
- Butler Hospital has 2 upcoming primary-completion readouts tracked here; the soonest is “Methadone-Maintained Smokers Switching to E-Cigarettes”, expected around 2025-06-30.